Annual Cash & Cash Equivalents
$7.47 M
-$1.64 M-17.97%
December 31, 2023
Summary
- As of February 7, 2025, ACXP annual cash & cash equivalents is $7.47 million, with the most recent change of -$1.64 million (-17.97%) on December 31, 2023.
- During the last 3 years, ACXP annual cash & cash equivalents has risen by +$4.30 million (+135.38%).
- ACXP annual cash & cash equivalents is now -42.32% below its all-time high of $12.96 million, reached on December 31, 2021.
Performance
ACXP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.76 M
-$598.30 K-9.41%
September 30, 2024
Summary
- As of February 7, 2025, ACXP quarterly cash and cash equivalents is $5.76 million, with the most recent change of -$598.30 thousand (-9.41%) on September 30, 2024.
- Over the past year, ACXP quarterly cash and cash equivalents has dropped by -$1.29 million (-18.29%).
- ACXP quarterly cash and cash equivalents is now -66.29% below its all-time high of $17.10 million, reached on June 30, 2021.
Performance
ACXP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACXP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.0% | -18.3% |
| 3 y3 years | +135.4% | -37.0% |
| 5 y5 years | +201.0% | -37.0% |
ACXP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.3% | at low | -55.5% | at low |
| 5 y | 5-year | -42.3% | +201.0% | -66.3% | +119.3% |
| alltime | all time | -42.3% | +201.0% | -66.3% | +119.3% |
Acurx Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.76 M(-9.4%) |
| Jun 2024 | - | $6.36 M(-28.7%) |
| Mar 2024 | - | $8.92 M(+19.4%) |
| Dec 2023 | $7.47 M(-18.0%) | $7.47 M(+6.0%) |
| Sep 2023 | - | $7.05 M(-22.9%) |
| Jun 2023 | - | $9.15 M(+27.4%) |
| Mar 2023 | - | $7.18 M(-21.2%) |
| Dec 2022 | $9.11 M | $9.11 M(-14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $10.61 M(+16.7%) |
| Jun 2022 | - | $9.09 M(-18.0%) |
| Mar 2022 | - | $11.08 M(-14.5%) |
| Dec 2021 | $12.96 M(+308.1%) | $12.96 M(-10.4%) |
| Sep 2021 | - | $14.46 M(-15.4%) |
| Jun 2021 | - | $17.10 M(+550.4%) |
| Mar 2021 | - | $2.63 M(-17.2%) |
| Dec 2020 | $3.18 M(+27.9%) | $3.18 M |
| Dec 2019 | $2.48 M | - |
FAQ
- What is Acurx Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Acurx Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Acurx Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ACXP is $7.47 M
What is the all time high annual cash & cash equivalents for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual cash & cash equivalents is $12.96 M
What is Acurx Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ACXP annual cash & cash equivalents has changed by -$1.64 M (-17.97%)
What is Acurx Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACXP is $5.76 M
What is the all time high quarterly cash and cash equivalents for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly cash and cash equivalents is $17.10 M
What is Acurx Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ACXP quarterly cash and cash equivalents has changed by -$1.29 M (-18.29%)